| Advanced Healthcare Of Mesa | |
| 5755 East Main Street, Mesa, Arizona 85205 | |
| (480) 214-2400 | |
| Name | Advanced Healthcare Of Mesa |
|---|---|
| Location | 5755 East Main Street, Mesa, Arizona |
| Certified By | Medicare |
| No. of Certified Beds | 38 |
| Occupancy Rate | 91.84% |
| Medicare ID (CCN) | 035266 |
| Legal Business Name | Ahc Of Mesa Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1295768620 |
| Organization Name | AHC OF MESA LLC |
| Doing Business As | ADVANCED HEALTH CARE OF MESA |
| Address | 5755 E Main St, Mesa, AZ 85205 |
| Phone Number | 480-214-2400 |
News Archive
Taking vitamin A supplements reduces the risk for developing a deadly form of skin cancer called melanoma, say US researchers.
MedRisk, Inc. has entered into an agreement with Coventry Workers' Comp Services (CWCS), a division of Coventry Health Care, Inc.
Coal dust exposure is directly linked to severity of emphysema in smokers and nonsmokers alike, according to new research from the National Institute for Occupational Safety and Health (NIOSH).
Vanderbilt University and Bristol-Myers Squibb Company announced today that they have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators or PAMs, for the treatment of Parkinson's disease.
› Verified 5 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Taking vitamin A supplements reduces the risk for developing a deadly form of skin cancer called melanoma, say US researchers.
MedRisk, Inc. has entered into an agreement with Coventry Workers' Comp Services (CWCS), a division of Coventry Health Care, Inc.
Coal dust exposure is directly linked to severity of emphysema in smokers and nonsmokers alike, according to new research from the National Institute for Occupational Safety and Health (NIOSH).
Vanderbilt University and Bristol-Myers Squibb Company announced today that they have signed a collaboration agreement for the discovery, development and commercialization of novel therapies acting on the mGluR4 glutamate receptor, known as positive allosteric modulators or PAMs, for the treatment of Parkinson's disease.
› Verified 5 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|